Australia
· Delayed Price · Currency is AUD Radiopharm Theranostics Statistics
Total Valuation
ASX:RAD has a market cap or net worth of AUD 49.01 million. The enterprise value is 11.38 million.
| Market Cap | 49.01M |
| Enterprise Value | 11.38M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:RAD has 2.33 billion shares outstanding. The number of shares has increased by 243.78% in one year.
| Current Share Class | 2.33B |
| Shares Outstanding | 2.33B |
| Shares Change (YoY) | +243.78% |
| Shares Change (QoQ) | +327.30% |
| Owned by Insiders (%) | 11.19% |
| Owned by Institutions (%) | 5.92% |
| Float | 1.51B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 148.24 |
| PB Ratio | 0.94 |
| P/TBV Ratio | 9.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.26 |
| EV / Sales | 34.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.37
| Current Ratio | 3.37 |
| Quick Ratio | 3.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -59.53 |
Financial Efficiency
Return on equity (ROE) is -112.21% and return on invested capital (ROIC) is -59.05%.
| Return on Equity (ROE) | -112.21% |
| Return on Assets (ROA) | -28.95% |
| Return on Invested Capital (ROIC) | -59.05% |
| Return on Capital Employed (ROCE) | -45.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.00% in the last 52 weeks. The beta is 0.80, so ASX:RAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -40.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 41.67 |
| Average Volume (20 Days) | 1,860,542 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:RAD had revenue of AUD 330,628 and -43.00 million in losses. Loss per share was -0.04.
| Revenue | 330,628 |
| Gross Profit | -21.38M |
| Operating Income | -36.07M |
| Pretax Income | -42.67M |
| Net Income | -43.00M |
| EBITDA | -32.99M |
| EBIT | -36.07M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 36.44 million in cash and n/a in debt, giving a net cash position of 36.44 million or 0.02 per share.
| Cash & Cash Equivalents | 36.44M |
| Total Debt | n/a |
| Net Cash | 36.44M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 52.00M |
| Book Value Per Share | 0.02 |
| Working Capital | 31.21M |
Cash Flow
| Operating Cash Flow | -33.42M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -10,908.64% |
| Pretax Margin | -12,905.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:RAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -243.78% |
| Shareholder Yield | n/a |
| Earnings Yield | -87.74% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ASX:RAD has an Altman Z-Score of -2.23. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.23 |
| Piotroski F-Score | n/a |